DMAC - CIK 0001401040
DiaMedica Therapeutics Inc. has filed 414 documents with the SEC between 2007 and 2026. The most frequent type is insider trade (143 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Major company event | 8-K | 2026-05-21 | 2026-05-20 |
| Quarterly report | 10-Q | 2026-05-06 | 2026-03-31 |
| Major company event | 8-K | 2026-05-06 | 2026-05-06 |
| Annual report to shareholders | ARS | 2026-04-01 | 2025-12-31 |
| Proxy materials | DEFA14A | 2026-04-01 | - |
| Proxy statement | DEF 14A | 2026-04-01 | 2026-05-20 |
| Major company event | 8-K | 2026-03-31 | 2026-03-30 |
| Annual report | 10-K | 2026-03-30 | 2025-12-31 |
| SCHEDULE 13G/A | - | 2026-02-17 | - |
| SCHEDULE 13G/A | - | 2026-02-17 | - |
| SCHEDULE 13G/A | - | 2026-02-06 | - |
| Insider trade | 4 | 2026-01-06 | 2026-01-02 |
| Insider trade | 4 | 2026-01-06 | 2026-01-02 |
| Insider trade | 4 | 2026-01-06 | 2026-01-02 |
| Major company event | 8-K | 2026-01-05 | 2026-01-05 |
| Major company event | 8-K | 2025-12-18 | 2025-12-18 |
| Insider trade | 4 | 2025-12-08 | 2025-11-17 |
| Insider trade | 4 | 2025-11-25 | 2025-11-21 |
| Employee stock plan | S-8 | 2025-11-13 | - |
| Quarterly report | 10-Q | 2025-11-12 | 2025-09-30 |
| Major company event | 8-K | 2025-11-12 | 2025-11-12 |
| SCHEDULE 13G/A | - | 2025-11-07 | - |
| Insider trade | 4 | 2025-11-03 | 2025-08-11 |
| New insider ownership | 3 | 2025-11-03 | 2025-08-11 |
| SCHEDULE 13G/A | - | 2025-10-15 | - |
| Insider trade | 4 | 2025-09-04 | 2025-08-13 |
| SCHEDULE 13G/A | - | 2025-09-04 | - |
| SCHEDULE 13G | - | 2025-08-27 | - |
| EFFECT | - | 2025-08-22 | - |
| Prospectus supplement | 424B2 | 2025-08-22 | - |
| Company correspondence | CORRESP | 2025-08-20 | - |
| SEC correspondence | UPLOAD | 2025-08-18 | - |
| Major company event | 8-K | 2025-08-12 | 2025-08-12 |
| Securities registration | S-3 | 2025-08-12 | - |
| Quarterly report | 10-Q | 2025-08-12 | 2025-06-30 |
| Major company event | 8-K | 2025-08-12 | 2025-08-12 |
| EFFECT | - | 2025-08-08 | - |
| Company correspondence | CORRESP | 2025-08-06 | - |
| Major company event | 8-K | 2025-08-06 | 2025-08-04 |
| SEC correspondence | UPLOAD | 2025-08-05 | - |
| Securities registration | S-3 | 2025-08-01 | - |
| SCHEDULE 13G/A | - | 2025-07-30 | - |
| SCHEDULE 13G/A | - | 2025-07-30 | - |
| Insider trade | 4 | 2025-07-25 | 2025-07-23 |
| D | - | 2025-07-25 | - |
| Insider trade | 4 | 2025-07-25 | 2025-07-23 |
| Insider trade | 4 | 2025-07-25 | 2025-07-23 |
| Major company event | 8-K | 2025-07-21 | 2025-07-21 |
| Major company event | 8-K | 2025-07-17 | 2025-07-17 |
| Insider trade | 4 | 2025-06-03 | 2025-06-01 |